{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:28:46Z","timestamp":1792301326822,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00707-x","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:50:41Z","timestamp":1739958641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuropsychiatric and laboratory outcomes of hepatitis C treatment in an early-treated HIV cohort in Thailand"],"prefix":"10.1186","volume":"22","author":[{"given":"Ferron","family":"Ocampo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sacdalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suteeraporn","family":"Pinyakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misti","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanyaporn","family":"Wansom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathornsorn","family":"Poltubtim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Sriplienchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donn","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Spudich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the RV254\/SEARCH 010 Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"7","key":"707_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","volume":"16","author":"L Platt","year":"2016","unstructured":"Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797\u2013808.","journal-title":"Lancet Infect Dis"},{"issue":"9772","key":"707_CR2","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0140-6736(10)62001-6","volume":"377","author":"D Joshi","year":"2011","unstructured":"Joshi D, O\u2019Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. The Lancet. 2011;377(9772):1198\u2013209.","journal-title":"The Lancet"},{"issue":"3","key":"707_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1586\/17474124.2014.876357","volume":"8","author":"W Kang","year":"2014","unstructured":"Kang W, Tong HI, Sun Y, Lu Y. Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management. Expert Rev Gastroenterol Hepatol. 2014;8(3):247\u201366.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"707_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jvh.12447","volume":"23","author":"JV Fern\u00e1ndez-Montero","year":"2015","unstructured":"Fern\u00e1ndez-Montero JV, Barreiro P, de Mendoza C, Labarga P, Soriano V. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients. J Viral Hepatitis. 2015;23(1):47\u201352.","journal-title":"J Viral Hepatitis"},{"issue":"2","key":"707_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jare.2016.09.005","volume":"8","author":"L Yarlott","year":"2017","unstructured":"Yarlott L, Heald E, Forton D. Hepatitis C virus infection, and neurological and psychiatric disorders \u2013 A review. J Adv Res. 2017;8(2):139\u201348.","journal-title":"J Adv Res"},{"issue":"4","key":"707_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/2050640619835394","volume":"7","author":"D Chromy","year":"2019","unstructured":"Chromy D, Mandorfer M, Bucsics T, Schwabl P, Scheiner B, Schmidbauer C, et al. High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients. United Euro Gastroenterol J. 2019;7(4):507\u201316.","journal-title":"United Euro Gastroenterol J"},{"issue":"1","key":"707_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1515\/jtim-2017-0007","volume":"5","author":"A Geddawy","year":"2017","unstructured":"Geddawy A, Ibrahim YF, Elbahie NM, Ibrahim MA. Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction. J Trans Int Med. 2017;5(1):8\u201317.","journal-title":"J Trans Int Med"},{"issue":"12","key":"707_CR8","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3390\/diagnostics11122336","volume":"11","author":"A Marino","year":"2021","unstructured":"Marino A, Zafarana G, Ceccarelli M, Cosentino F, Moscatt V, Bruno G, et al. Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV\/HCV Coinfected Patients: Monocentric Italian Experience. Diagnostics. 2021;11(12):2336.","journal-title":"Diagnostics"},{"issue":"11","key":"707_CR9","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/apt.15240","volume":"49","author":"HB El-Serag","year":"2019","unstructured":"El-Serag HB, Christie IC, Puenpatom A, Castillo D, Kanwal F, Kramer JR. The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection. Aliment Pharmacol Ther. 2019;49(11):1442\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"707_CR10","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/jvh.13584","volume":"28","author":"C Santos-Lima","year":"2021","unstructured":"Santos-Lima C, Souza-Marques B, Vieira F, Isabel Schinoni M, Quarantini LC, Abreu N. Neuropsychological effects of direct-acting antiviral treatment for Hepatitis C virus subjects: A systematic review. J Viral Hepat. 2021;28(12):1672\u201382.","journal-title":"J Viral Hepat"},{"issue":"1","key":"707_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S2055-6640(20)30688-9","volume":"2","author":"J Ananworanich","year":"2016","unstructured":"Ananworanich J, Sacdalan CP, Pinyakorn S, Chomont N, de Souza M, Luekasemsuk T, et al. Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection. J Virus Erad. 2016;2(1):43\u20138.","journal-title":"J Virus Erad"},{"issue":"1","key":"707_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/2224-3151.206162","volume":"6","author":"S Supanya","year":"2017","unstructured":"Supanya S, Kongsuk T, Kenbubpha K, Phimtra S, Sukhawaha S, Leejongpermpoon J. Services for depression and suicide in Thailand. WHO South-East Asia Journal of Public Health. 2017;6(1):34.","journal-title":"WHO South-East Asia Journal of Public Health"},{"issue":"1","key":"707_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-8-1","volume":"8","author":"M Lotrakul","year":"2008","unstructured":"Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC Psych. 2008;8(1):1\u20137.","journal-title":"BMC Psych"},{"issue":"3","key":"707_CR14","first-page":"257","volume":"58","author":"S Jetiyanuwat","year":"2013","unstructured":"Jetiyanuwat S. Validity of the Thai version of the distress thermometer. J Psych Assoc Thailand. 2013;58(3):257\u201370.","journal-title":"J Psych Assoc Thailand"},{"issue":"9","key":"707_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"707_CR16","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X","volume":"82","author":"AJ Roth","year":"1998","unstructured":"Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma. Cancer. 1998;82(10):1904\u20138.","journal-title":"Cancer"},{"issue":"1","key":"707_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13803395.2012.733682","volume":"35","author":"J Heaps","year":"2013","unstructured":"Heaps J, Valcour V, Chalermchai T, Paul R, Rattanamanee S, Siangphoe U, et al. Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders. J Clin Exp Neuropsychol. 2013;35(1):1\u20138.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"4","key":"707_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/QAI.0000000000002356","volume":"84","author":"T Wansom","year":"2020","unstructured":"Wansom T, Pinyakorn S, Kolsteeg CJ, Kroon E, Sacdalan CP, Chomchey N, et al. Brief Report: group sex and methamphetamine use fuel an explosive epidemic of Hepatitis C among HIV-infected men who have sex with men in Bangkok. Thailand J Acquir Immune Defic Syndr. 2020;84(4):331\u20135.","journal-title":"Thailand J Acquir Immune Defic Syndr"},{"issue":"9","key":"707_CR19","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1111\/liv.14578","volume":"40","author":"WM Han","year":"2020","unstructured":"Han WM, Colby DJ, Khlaiphuengsin A, Apornpong T, Kerr SJ, Ubolyam S, et al. Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok. Thailand Liver Int. 2020;40(9):2104\u20139.","journal-title":"Thailand Liver Int"},{"issue":"19","key":"707_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020156","volume":"99","author":"YC Chen","year":"2020","unstructured":"Chen YC, Tseng CW, Tseng KC. Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents. Medicine. 2020;99(19): e20156.","journal-title":"Medicine"},{"issue":"22","key":"707_CR21","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1182\/blood.V128.22.5967.5967","volume":"128","author":"H Rafei","year":"2016","unstructured":"Rafei H, Ascensao JL, Aggarwal A. Platelet Count Increase Seen with Ledipasvir-Sofosbuvir Combination Treatment of Chronic Hepatitis C in Patients with Thrombocytopenia. Blood. 2016;128(22):5967.","journal-title":"Blood"},{"issue":"2021","key":"707_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8811203","volume":"23","author":"M Saif-Al-Islam","year":"2021","unstructured":"Saif-Al-Islam M, Abdelaal UM, Younis MA, Alghany Algahlan HA, Khalaf S. Effect of direct-acting antiviral therapy on thrombocytopenic patients with hepatitis C virus-related chronic liver disease. Gastroenterol Res Pract. 2021;23(2021):1\u201310.","journal-title":"Gastroenterol Res Pract"},{"issue":"26","key":"707_CR23","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.3748\/wjg.v23.i26.4669","volume":"23","author":"D Lib\u00e2nio","year":"2017","unstructured":"Lib\u00e2nio D, Marinho RT. Impact of hepatitis C oral therapy in portal hypertension. World J Gastroenterol. 2017;23(26):4669\u201374.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"707_CR24","doi-asserted-by":"publisher","first-page":"1435124","DOI":"10.1080\/19932820.2018.1435124","volume":"13","author":"G El Sagheer","year":"2018","unstructured":"El Sagheer G, Soliman E, Ahmad A, Hamdy L. Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs. Libyan J Med. 2018;13(1):1435124.","journal-title":"Libyan J Med"},{"issue":"6","key":"707_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/jmv.25062","volume":"90","author":"HI Shousha","year":"2018","unstructured":"Shousha HI, Abdelaziz RA, Azab SM, Khairy M, Afifi SA, Mehrez MI, et al. Effect of treatment with direct acting antivirals on body mass index and hepatic steatosis in chronic hepatitis C. J Med Virol. 2018;90(6):1099\u2013105.","journal-title":"J Med Virol"},{"issue":"2","key":"707_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21608\/mjvh.2021.158275","volume":"52","author":"A Menesy","year":"2021","unstructured":"Menesy A, Ehab A, Abbas N. Impact of direct-acting antiviral agents treatment on body mass index and lipid profile in Egyptian Chronic Hepatitis C patients. Med J Viral Hepat. 2021;52(2):21\u20136.","journal-title":"Med J Viral Hepat"},{"issue":"7","key":"707_CR27","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/v13071402","volume":"13","author":"M Spaziante","year":"2021","unstructured":"Spaziante M, Taliani G, Marchetti G, Tavelli A, Lichtner M, Cingolani A, et al. Impact of HCV Eradication on Lipid Metabolism in HIV\/HCV coinfected patients: data from ICONA and HepaICONA Foundation Cohort Study. Viruses. 2021;13(7):1402.","journal-title":"Viruses"},{"issue":"1","key":"707_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5604\/01.3001.0010.7536","volume":"17","author":"S Gitto","year":"2018","unstructured":"Gitto S, Cicero AFG, Loggi E, Giovannini M, Conti F, Grandini E, et al. Worsening of serum lipid profile after direct acting antiviral treatment. Ann Hepatol. 2018;17(1):64\u201375.","journal-title":"Ann Hepatol"},{"issue":"5","key":"707_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/QAD.0000000000001745","volume":"32","author":"SJ Willis","year":"2018","unstructured":"Willis SJ, Cole SR, Westreich D, Edmonds A, Hurt CB, Albrecht S, et al. Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy. AIDS. 2018;32(5):653\u201361.","journal-title":"AIDS"},{"issue":"12","key":"707_CR30","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1097\/QAD.0000000000000650","volume":"29","author":"O Zaegel-Faucher","year":"2015","unstructured":"Zaegel-Faucher O, Bregigeon S, Cano CE, Obry-Roguet V, Nicolino-Brunet C, Tamalet C, et al. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy. AIDS. 2015;29(12):1505\u201310.","journal-title":"AIDS"},{"key":"707_CR31","doi-asserted-by":"crossref","unstructured":"Kuniholm MH, O\u02bcBrien TR, Prokunina-Olsson L, Augenbraun M, Plankey M, Karim R, et al. Association of Hepatitis C Virus Infection With CD4\/CD8 Ratio in HIV-Positive Women. J Acquir Immune Defic Syndr. 2016;72(2):162\u201370.","DOI":"10.1097\/QAI.0000000000000928"},{"issue":"5","key":"707_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/jvh.13488","volume":"28","author":"A Bandera","year":"2021","unstructured":"Bandera A, Lorenzini P, Taramasso L, Cozzi-Lepri A, Lapadula G, Mussini C, et al. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV\/HCV coinfected patients: Data from the ICONA Foundation Cohort. J Viral Hepat. 2021;28(5):779\u201386.","journal-title":"J Viral Hepat"},{"issue":"4","key":"707_CR33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/infdis\/jiy136","volume":"218","author":"LF L\u00f3pez-Cort\u00e9s","year":"2018","unstructured":"L\u00f3pez-Cort\u00e9s LF, Trujillo-Rodr\u00edguez M, B\u00e1ez-Palomo A, Benmarzouk-Hidalgo OJ, Dominguez-Molina B, Milan\u00e9s-Guisado Y, et al. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV\/HCV-Coinfected Patients. J Infect Dis. 2018;218(4):624\u201332.","journal-title":"J Infect Dis"},{"issue":"4","key":"707_CR34","doi-asserted-by":"publisher","first-page":"610.e1","DOI":"10.1016\/j.cmi.2021.08.019","volume":"28","author":"M Laguno","year":"2022","unstructured":"Laguno M, Mart\u00ednez-Rebollar M, Casanova M, de Lazzari E, Gonz\u00e1lez-Cord\u00f3n A, Torres B, et al. Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients. Clin Microbiol Infect. 2022;28(4):610.e1-e7.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"707_CR35","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3748\/wjg.v21.i8.2269","volume":"21","author":"LE Adinolfi","year":"2015","unstructured":"Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, et al. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol. 2015;21(8):2269\u201380.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"707_CR36","first-page":"131","volume":"35","author":"HJ von Giesen","year":"2004","unstructured":"von Giesen HJ, Heintges T, Abbasi-Boroudjeni N, K\u00fcc\u00fckk\u00f6yl\u00fc S, K\u00f6ller H, Haslinger BA, et al. Psychomotor Slowing in Hepatitis C and HIV infection. JAIDS. 2004;35(2):131\u20137.","journal-title":"JAIDS"},{"issue":"Suppl 3","key":"707_CR37","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1097\/01.aids.0000192072.80572.43","volume":"19","author":"DB Clifford","year":"2005","unstructured":"Clifford DB, Evans SR, Yang Y, Gulick RM. The neuropsychological and neurological impact of hepatitis C virus coinfection in HIV-infected subjects. AIDS. 2005;19(Suppl 3):S64-71.","journal-title":"AIDS"},{"issue":"9","key":"707_CR38","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","volume":"74","author":"R Nemni","year":"2003","unstructured":"Nemni R. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry. 2003;74(9):1267\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"707_CR39","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1111\/liv.15002","volume":"41","author":"MM Zanone","year":"2021","unstructured":"Zanone MM, Marinucci C, Ciancio A, Cocito D, Zardo F, Spagone E, et al. Peripheral neuropathy after viral eradication with direct-acting antivirals in chronic HCV hepatitis: A prospective study. Liver Int. 2021;41(11):2611\u201321.","journal-title":"Liver Int"},{"issue":"5","key":"707_CR40","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/diagnostics12051177","volume":"12","author":"CM Danilescu","year":"2022","unstructured":"Danilescu CM, Ionescu M, Sandulescu DL, Pirlog MC, Streba CT, Rogoveanu I. Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy. Diagnostics. 2022;12(5):1177.","journal-title":"Diagnostics"},{"issue":"3","key":"707_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1188\/17.ONF.329-336","volume":"44","author":"A Cutillo","year":"2017","unstructured":"Cutillo A, O\u2019Hea E, Person S, Lessard D, Harralson T, Boudreaux E. The Distress Thermometer: Cutoff Points and Clinical Use. Oncol Nurs Forum. 2017;44(3):329\u201336.","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"707_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/jhep.2002.31257","volume":"35","author":"RC Hilsabeck","year":"2002","unstructured":"Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002;35(2):440\u20136.","journal-title":"Hepatology"},{"issue":"6","key":"707_CR43","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1017\/S1355617703960048","volume":"9","author":"RC Hilsabeck","year":"2003","unstructured":"Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc. 2003;9(6):847\u201357.","journal-title":"J Int Neuropsychol Soc"},{"issue":"4","key":"707_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11901-007-0017-4","volume":"6","author":"R Paul","year":"2007","unstructured":"Paul R, Letendre S, Dearborn J. Impact of hepatitis C coinfection on cognitive outcomes in HIV-infected individuals. Curr hepatitis rep. 2007;6(4):145\u201352.","journal-title":"Curr hepatitis rep"},{"issue":"1\u20132","key":"707_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jns.2011.08.025","volume":"312","author":"P Vivithanaporn","year":"2012","unstructured":"Vivithanaporn P, Nelles K, DeBlock L, Newman SC, Gill MJ, Power C. Hepatitis C virus coinfection increases neurocognitive impairment severity and risk of death in treated HIV\/AIDS. J Neurol Sci. 2012;312(1\u20132):45\u201351.","journal-title":"J Neurol Sci"},{"issue":"2","key":"707_CR46","first-page":"190","volume":"62","author":"B Sun","year":"2013","unstructured":"Sun B, Abadjian L, Rempel H, Monto A, Pulliam L. Differential Cognitive Impairment in HCV Coinfected Men With Controlled HIV Compared to HCV Monoinfection. JAIDS. 2013;62(2):190\u20136.","journal-title":"JAIDS"},{"key":"707_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fneur.2021.602263","volume":"12","author":"RH Paul","year":"2021","unstructured":"Paul RH, Shikuma CM, Chau NVV, Ndhlovu LC, Thanh NT, Belden AC, et al. Neurocognitive Trajectories After 72 Weeks of First-Line Anti-retroviral Therapy in Vietnamese Adults With HIV-HCV Coinfection. Front Neurol. 2021;12:12.","journal-title":"Front Neurol"},{"issue":"5","key":"707_CR48","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13365-018-0647-z","volume":"24","author":"F Kleefeld","year":"2018","unstructured":"Kleefeld F, Heller S, Ingiliz P, Jessen H, Petersen A, Kopp U, et al. Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV\/HIV coinfected patients: effect on cognitive function, fatigue, and mental health. J Neurovirol. 2018;24(5):557\u201369.","journal-title":"J Neurovirol"},{"issue":"3","key":"707_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/infdis\/jiaa109","volume":"222","author":"B Sun","year":"2020","unstructured":"Sun B, Abadjian L, Monto A, Freasier H, Pulliam L. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms. J Infect Dis. 2020;222(3):396\u2013406.","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"707_CR50","first-page":"S222","volume":"97","author":"P Sithinamsuwan","year":"2014","unstructured":"Sithinamsuwan P, Hutchings N, Ananworanich J, Wendelken L, Saengtawan P, Paul R, et al. Practice effect and normative data of an HIV-specific neuropsychological testing battery among healthy Thais. J Med Assoc Thai. 2014;97(Suppl 2):S222\u201333.","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"707_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","volume":"19","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review. Neuropsychol Rev. 2009;19(2):169\u201385.","journal-title":"Neuropsychol Rev"},{"issue":"10","key":"707_CR52","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/QAD.0000000000001848","volume":"32","author":"RA Hughes","year":"2018","unstructured":"Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, et al. Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+\u202f: CD8+ ratio. AIDS. 2018;32(10):1361\u20137.","journal-title":"AIDS"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00707-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:50:46Z","timestamp":1739958646000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00707-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00707-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4186965\/v1","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review boards of all relevant collaborating institutions. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The RV254\/SEARCH 010 study participants received antiretroviral drugs from the Thai Government Pharmaceutical Organization, Gilead Science, Merck, and ViiV Healthcare. SS reports grants from the NIH\u2013NIMH and NINDS during the study and nonfinancial support from ViiV Healthcare, Inc., in the form of medications for a clinical trial; study medications were provided to the AIDS Clinical Trials Group for the clinical trial, outside the submitted work. RP and LT reports grants from the NIH\u2013NIMH and NIAID. The other authors report no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}